altRX Review
Best for: Buyers who want the broadest possible brand-name FDA-approved GLP-1 access on a single platform — altRX is the only provider in the WLR directory offering all four (Mounjaro / Ozempic / Wegovy / Zepbound) alongside compounded options. Strong fit for patients who may switch between compounded and brand-name depending on response, supply, or insurance situation.
altRX (altrx.com) is a **dual-modality** telehealth platform offering both compounded GLP-1 and **all four brand-name FDA-approved GLP-1 medications** — Mounjaro®, Ozempic®, Wegovy®, AND Zepbound® — which is the most comprehensive brand-name access in the WLR directory (most dual-modality competitors offer 1-2 brand-name options). Corporate structure: 'CareGLP Affiliated P.C.s' (Professional Corporations) + CareValidate Health (affiliated telemedicine network). LegitScript Certified ID **48475686** (verifiable). Verbatim FDA disclaimer: 'Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. Prescription required.' Pricing: GLP-1 (compounded) starting at $149; GLP-1/GIP (compounded tirzepatide) starting at $249; Ozempic® $1,149; Mounjaro® $1,249; Zepbound® $1,249; Wegovy® $1,579. Pricing INCLUDES 'consult, prescription process, and shipping/delivery.' Approval 'In 1 day' framing. 'Get Upto $140 Off Today' promotional pricing. Telemedicine network: CareValidate Health. 'Compounded GLP-1s are produced in FDA-regulated facilities' (503A vs 503B not specified). Cancel anytime. Multiple USA-certified pharmacies (not named individually). 4.4-star rating 'Based on thousands of happy clients' (per site claim). NOT disclosed publicly: states-served list, specific pharmacy partner names, named medical director, governing law, corporate physical address. Live-verified 2026-05-20.
Medium confidence · Last verified 2026-05-20 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
altRX is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
altRX prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Compounded GLP-1 (semaglutide) starting tier | compounded | $149 |
| Compounded GLP-1/GIP (tirzepatide) starting tier | compounded | $249 |
| Brand-name Ozempic® | brand | $1149 |
| Brand-name Mounjaro® | brand | $1249 |
| Brand-name Zepbound® | brand | $1249 |
| Brand-name Wegovy® | brand | $1579 |
✓ Pros
- •**ALL FOUR brand-name FDA-approved GLP-1s offered** (Mounjaro, Ozempic, Wegovy, Zepbound) — the most comprehensive brand-name access in the WLR directory. Most dual-modality competitors offer only 1-2 brand-name options; altRX covers the full FDA-approved set.
- •LegitScript Certified with publicly verifiable ID (48475686)
- •Verbatim FDA compounded-medication disclaimer published — meets WLR transparency standard
- •Pricing transparent across all 6 product tiers (compounded + 4 brand-name)
- •All-inclusive pricing (consult + prescription + shipping) — no hidden fees framing
- •Corporate structure disclosed (CareGLP Affiliated P.C.s + CareValidate Health) — Professional Corporation designation visible
- •1-day approval framing — faster than typical 24-72hr competitors
- •Brand-name pricing competitive vs retail cash-pay ($1,149-$1,579 vs $1,350-$1,400 typical retail)
✗ Cons
- •States-served list NOT disclosed publicly
- •Specific 503A/503B pharmacy partner NOT named (only 'multiple USA-certified pharmacies' generic)
- •503A vs 503B compounding designation NOT specified
- •Named medical director NOT disclosed
- •Corporate physical address NOT disclosed
- •Governing law / arbitration venue NOT disclosed
- •Refund policy linked but full text not browsed
- •Brand-name pricing is cash-pay only (no insurance pathway) — patients with commercial Wegovy/Ozempic coverage should price-check elsewhere first
- •'CareGLP Affiliated P.C.s' framing is unusual — affiliated-PC structure may indicate state-by-state professional corporation setup vs single national entity
Ready to start with altRX?
Starting at $149/month. See current pricing and start your free consultation.
Sources & methodology
Our altRX review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to altRX
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with altRX?
Starting at $149/month. See current pricing and start your free consultation.